Robert Conway

Bob Conway served as the Chief Executive Officer and member of the Board of Directors of Array BioPharma (NASDAQ: ARRY) from 1999 to 2012. Array is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Array was acquired by Pfizer in 2019.

Prior to joining Array, Bob Conway was the Chief Operating Officer and Executive Vice President of Hill Top Research, Inc., a clinical research services company, from 1996 to 1999. He also held various executive positions for Corning Inc . (NYSE: GLW) including Corporate Vice President and General Manager of Corning Hazleton, Inc., a contract research organization, from 1979 to 1996.

Bob Conway serves as Chairman of ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. He is on the Board of Directors of Alpine Immune Sciences, an oncology-focused biotech (NASDAQ:ALPN). Previously he was Chairman of Wall Family Enterprise, a leading library and education supplies company. He served as a Director of eResearch Technology and PRA International, Inc. prior Genstar companies and currently serves as a Director of Advarra and Signant Health, two of Genstar’s portfolio companies.